Lengo Therapeutics
San Diego
About Lengo Therapeutics
Lengo Therapeutics a biopharmaceutical company focused on the discovery and development of cancer treatments. Lengo works to identify several mutations in cancers that were not well addressed by existing therapeutics, helping medical practitioners and pharma companies to target driver mutations in oncology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.0M
- Funding stage: M&A
- Last round: Series A (May 2020)
- Website: lengotx.com
- Phone: 858-500-5188
Industries & Categories
Biotechnology, Medical, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/lengo-therapeutics-97581 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.